Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
FDA approves new treatment for adults with relapsed or refractory large-b-cell lymphoma
Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy […]
Honeywell to produce and donate hand sanitizer to support local needs amid Covid-19 pandemic
Honeywell today announced that it is temporarily shifting manufacturing operations at two chemical manufacturing facilities […]
Honeywell and Wolters Kluwer team up to help employees safely return to the workplace
Honeywell and Wolters Kluwer today announced a collaboration to integrate Honeywell’s Industrial Internet of Things […]
NHSX: AI at the Forefront of Efforts to Treat Coronavirus Patients
NHSX, a unit tasked with driving the digital transformation of care in the NHS, has […]
FDA statement on following the authorized dosing schedules for COVID-19 vaccines
Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 […]
Moderna announces FDA Authorization of Moderna COVID-19 vaccine in U.S.
Moderna, Inc., a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that […]
Pfizer and BionTech achieve first authorization in the world for a vaccine to combat Covid-19
Pfizer Inc. and BioNTech SE announced today that the Medicines & Healthcare Products Regulatory Agency (MHRA) in […]
Surging Nanotech Investments Boost Global Healthcare and Pandemic Protection
COVID-19’s outbreak has coincided with investments flooding into nanotech-based healthcare companies, according to Pitchbook‘s latest […]
Cyber Tech Company Develops Corona Virus Digital Health Passport with VCode®
VST Enterprises Ltd (VSTE) the British cyber security company founded by tech entrepreneur Louis-James Davis […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more